| Overview |
| bsm-90181R |
| SPINK5 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human SPINK5 / LEKTI |
| 150-200/1064 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 11005 |
| Q9NQ38 |
| SPINK5; Serine Peptidase Inhibitor Kazal Type 5; LEKTI; VAKTI; LETKI; NETS; NS; Lympho-Epithelial Kazal-Type-Related Inhibitor; Lymphoepithelial Kazal-Type-Related Inhibitor; Serine Protease Inhibitor Kazal-Type 5; FLJ21544; FLJ97536; FLJ97596 ; FLJ99794; Serine Protease Inhibitor Kazal Type 5; DKFZp686K19184; DKFZP686K19184 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz